Oncology & Cancer

New ways to treat solid tumours

(Medical Xpress)—An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumour effects. 

Oncology & Cancer

Tissue-engineered prostate tumours shed light on cancer spread

The international team led by Dr. Jacqui McGovern, from the Centre for Biomedical Technologies, used tissue engineering and regenerative medicine principles to create primary tumors with their microenvironment and humanized ...

Oncology & Cancer

Metformin appeared to slow prostate cancer growth

The use of metformin in men with prostate cancer before prostatectomy helped to reduce certain metabolic parameters and slow the growth rate of the cancer, according to the results of a phase II study.

Oncology & Cancer

Repurposed drugs may halt the spread of cancer cells

For cancer cells to spread to other places in the body—or metastasize—they need to communicate with one another. One way they do this is through chemical messages delivered in exosomes, the molecules that carry information ...

Oncology & Cancer

Why combined therapies increase survival in prostate cancer

Researchers at Karolinska Institutet, SciLifeLab and Centre for Clinical Research, Västerås have been able to explain why a combination of castration therapy and radiation therapy increases survival rates for patients with ...

Oncology & Cancer

New breakthrough reveals how prostate cancer may begin

Researchers at the University of East Anglia have made an important discovery about how prostate cancer may start to develop. A new study published today in Molecular Oncology reveals that the prostate as a whole, including ...

Oncology & Cancer

Do prostate cancer cells have an Achilles' heel?

Researchers at the University of Illinois at Chicago describe new ways to selectively kill prostate cancer cells by exploiting the cells' revved-up metabolism. They report their findings in the online journal, eLife.

Oncology & Cancer

Theranostic drug personalizes prostate cancer imaging and therapy

A novel radionuclide drug tackles the challenge of prostate cancer imaging and takes a turn as a cancer-killing therapy for tumors in and out of the prostate, according to research presented during the 2015 Annual Meeting ...

page 11 from 40